HCWB•benzinga•
HCW Biologics Enters Exclusive Licensing Deal with WY Biotech for Immunotherapy Development; HCW Biologics To Receive Upfront Payment Of $7M And Is Eligible To Receive Additional Milestone Payments And Double-Digit Royalties On Future Product Sales
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 18, 2024 by benzinga